Metoclopramide Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Metoclopramide Hydrochloride
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Metoclopramide Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

21 API Suppliers, 10 USDMF, 4 CEP/COS, 1 JDMF, 3 EU WC, 9 NDC API, 15 Listed Suppliers, $ API Reference Price

21 API Suppliers
10 USDMF
4 CEP/COS
1 JDMF
3 EU WC
9 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

116 FDF Dossiers, 78 FDA Orange Book, 8 Europe, 8 Canada, 4 South Africa, 18 Listed Dossiers

116 FDF Dossiers
78 FDA Orange Book
8 Europe
8 Canada
4 South Africa
18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 5 Evonik, 5 Rochem International Inc, 18 SPI Pharma, 6 DKSH, 5 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 2 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 27 Kerry, 3 Lonza Capsugel, 16 Microlex e.U, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 28 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

86 Fillers, Diluents & Binders, 36 Direct Compression, 33 Disintegrants & Superdisintegrants, 29 Taste Masking, 23 Granulation, 22 Thickeners and Stabilizers, 19 Chewable & Orodispersible Aids, 19 Film Formers & Plasticizers, 17 Parenteral, 15 Co-Processed Excipients, 14 Lubricants & Glidants, 13 Coating Systems & Additives, 11 Solubilizers, 9 Controlled & Modified Release, 8 Empty Capsules, 6 Topical, 4 Emulsifying Agents, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Soft Gelatin

86 Fillers, Diluents & Binders
36 Direct Compression
33 Disintegrants & Superdisintegrants
29 Taste Masking
23 Granulation
22 Thickeners and Stabilizers
19 Chewable & Orodispersible Aids
19 Film Formers & Plasticizers
17 Parenteral
15 Co-Processed Excipients
14 Lubricants & Glidants
13 Coating Systems & Additives
11 Solubilizers
9 Controlled & Modified Release
8 Empty Capsules
6 Topical
4 Emulsifying Agents
1 Rheology Modifiers
1 API Stability Enhancers
1 Soft Gelatin

DIGITAL CONTENT

2 NEWS #PharmaBuzz

2 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

8 Finished Drug Prices

8 Finished Drug Prices

MARKET PLACE

10 APIs, 1 FDF Dossiers

10 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

1 EDQM
1 USP
1 Others

$ API Ref.Price (USD/KG) : 114 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4EVOKE PHARMA INC

filter Patent Number Reset all filters

4 All

01 18334281

02 111020361

03 111628150

04 111813231

filter API Patent Reset all filters

4 All

01 4Blank

filter FDF Patent Reset all filters

4 All

01 3Y

02 1Blank

filter Expiration Date Reset all filters

4 All

01 32029-12-22

02 12030-05-16

Metoclopramide Hydrochloride

Product Main Page

01

EVOKE PHARMA INC

METOCLOPRAMIDE HYDROCHLORIDE

The Generic Rx Session

Not Confirmed

EVOKE PHARMA INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-22

METOCLOPRAMIDE HYDROCHLORIDE

US Patent Number : 11020361

Drug Substance Claim :

Drug Product Claim :

Application Number : 209388

Patent Use Code : U-2843

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EVOKE PHARMA INC

METOCLOPRAMIDE HYDROCHLORIDE

The Generic Rx Session

Not Confirmed

EVOKE PHARMA INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-05-16

METOCLOPRAMIDE HYDROCHLORIDE

US Patent Number : 8334281

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209388

Patent Use Code : U-2843

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-05-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EVOKE PHARMA INC

METOCLOPRAMIDE HYDROCHLORIDE

The Generic Rx Session

Not Confirmed

EVOKE PHARMA INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-22

METOCLOPRAMIDE HYDROCHLORIDE

US Patent Number : 11628150

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209388

Patent Use Code : U-2843

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

EVOKE PHARMA INC

METOCLOPRAMIDE HYDROCHLORIDE

The Generic Rx Session

Not Confirmed

EVOKE PHARMA INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-22

METOCLOPRAMIDE HYDROCHLORIDE

US Patent Number : 11813231

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209388

Patent Use Code : U-2843

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!